Panacea Life Sciences Holdings, Inc. SEC filings PLSH
Panacea Life Sciences Holdings, Inc. has 316 filings in SEC EDGAR's recent list, going back to Aug 16, 2012. Its latest annual report, Form 10-K, was filed on Apr 1, 2024 for the period ended Dec 31, 2023. The latest quarterly report (Form 10-Q) was filed on May 6, 2024, covering the quarter ended Mar 31, 2024. The most recent current report (Form 8-K) was filed on May 16, 2024 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SEC STAFF ACTION | Filing | May 9, 2025 | — |
| 15-12G | Deregistration | Jul 16, 2024 | — |
| 1-A | Filing | Jun 11, 2024 | — |
| NT 10-Q | Filing | Aug 15, 2023 | Jun 30, 2023 |
| UPLOAD | Letter from the SEC | Jul 8, 2022 | — |
| CORRESP | Letter to the SEC | Jun 27, 2022 | — |
| UPLOAD | Letter from the SEC | May 27, 2022 | — |
| CORRESP | Letter to the SEC | May 17, 2022 | — |
| UPLOAD | Letter from the SEC | May 5, 2022 | — |
| SEC STAFF ACTION | Filing | Apr 25, 2022 | — |
| NT 10-Q | Filing | Nov 16, 2021 | Sep 30, 2021 |
| NT 10-Q | Filing | Aug 17, 2021 | Jun 30, 2021 |
| NT 10-Q | Filing | May 17, 2021 | Mar 31, 2021 |
| NT 10-K | Filing | Mar 30, 2021 | Dec 31, 2020 |
| D | Filing | Feb 18, 2021 | — |
| NT 10-Q | Filing | Nov 16, 2020 | Sep 30, 2020 |
| NT 10-Q | Filing | Aug 14, 2020 | Jun 30, 2020 |
| NT 10-Q | Filing | Jun 29, 2020 | Mar 31, 2020 |
| NT 10-K | Filing | May 14, 2020 | Dec 31, 2019 |
| NT 10-Q | Filing | May 15, 2019 | Mar 31, 2019 |
| D | Filing | Apr 12, 2019 | — |
| RW | Primary document | Mar 15, 2019 | — |
| D | Filing | Feb 22, 2019 | — |
| D | Filing | Jan 29, 2019 | — |
| NT 10-Q | Filing | Aug 15, 2018 | Jun 30, 2018 |
| NT 10-Q | Filing | May 15, 2018 | Mar 31, 2018 |
| NT 10-Q | Filing | Nov 15, 2017 | Sep 30, 2017 |
| 8-A12G | Filing | Aug 21, 2017 | — |
| 8-A12B | Filing | Aug 18, 2017 | — |
| D | Filing | Jan 20, 2017 | — |
| D | Filing | Nov 1, 2016 | — |
| CT ORDER | Filing | Sep 23, 2016 | — |
| NT 10-Q | Filing | Aug 15, 2016 | Jun 30, 2016 |
| D | Filing | Aug 5, 2016 | — |
| D | Filing | Dec 31, 2015 | — |
| EFFECT | Filing | Jul 1, 2015 | — |
| CORRESP | Letter to the SEC | Jun 29, 2015 | — |
| CORRESP | Letter to the SEC | Jun 19, 2015 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2015 | — |
| CORRESP | Letter to the SEC | Jun 11, 2015 | — |
| UPLOAD | Letter from the SEC | May 29, 2015 | — |
| CORRESP | Letter to the SEC | May 15, 2015 | — |
| UPLOAD | Letter from the SEC | Mar 10, 2015 | — |
| CORRESP | Letter to the SEC | Mar 21, 2014 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2014 | — |
| CORRESP | Letter to the SEC | Dec 19, 2013 | — |
| UPLOAD | Letter from the SEC | Sep 3, 2013 | — |
| CORRESP | Letter to the SEC | Aug 6, 2013 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2012 | — |
Showing 49 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- PLSH (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Greenwood Village, CO
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1552189
- Former names
- Exactus, Inc. (until Oct 26, 2021); Spiral Energy Tech., Inc. (until Mar 4, 2016); Solid Solar Energy, Inc. (until Aug 7, 2013)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.